GSK5460025
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK5460025, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]